ARTICLE | Clinical News
Biopool regulatory update
April 22, 1996 7:00 AM UTC
BIPL received 510(k) clearance to market Venom-Time, a clotting reagent that uses snake venom to detect abnormal or low levels of fibrinogen, a protein essential to blood clot formation. ...